Company News, Financial News

Johnson & Johnson Reports Worldwide Sales Increase of 1.3% in Fiscal 2022

Neutrogena was among the primary drivers for worldwide Consumer Health sales.

Author Image

By: Lianna Albrizio

Associate Editor

  Johnson & Johnson saw a worldwide increase of 1.3% in sales for fiscal year 2022, or $94.9 billion, the company reported on its official website.   Excluding acquisitions/divestitures on an operational basis, the worldwide increase was 6.2%.   Diluted earnings per share was $6.73 a decrease of 13.8%. Adjusted diluted earnings per share were $10.15, an increase of 3.6%.    Worldwide Consumer Health sales were $15.0 billion, a 0.5% decrease, but saw an operationa...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters